Newswise — Following an agreement signed between Israel’s Ministry of Health and the Weizmann Institute of Science, the Institute started conducting tests on April 12 to diagnose coronavirus. The tests will be carried out at the Nancy and Stephen Grand Israel National Center for Personalized Medicine, established by and operating at the Weizmann Institute of Science. The Grand Center’s world-class, cutting-edge lab facilities include advanced polymerase chain reaction (PCR) systems, which are capable of rapid and efficient gene identification.
The President of the Weizmann Institute of Science, Prof. Alon Chen, said: “As an integral part of Israeli society, we at the Weizmann Institute of Science consider it our duty and privilege to help and contribute to the State and the people of Israel in coping with the global coronavirus crisis. During this time of emergency, we are harnessing our basic research capabilities for the benefit of humanity.”
The Weizmann Institute of Science in Rehovot, Israel, is one of the world’s top-ranking multidisciplinary research institutions. The Institute’s 3,800-strong scientific community engages in research addressing crucial problems in medicine and health, energy, technology, agriculture, and the environment. Outstanding young scientists from around the world pursue advanced degrees at the Weizmann Institute’s Feinberg Graduate School. The discoveries and theories of Weizmann Institute scientists have had a major impact on the wider scientific community, as well as on the quality of life of millions of people worldwide.